involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol 2001; 12:353–56.
Lassman AB, Abrey LE, Shah G. Systemic high-dose intravenous methotrexate for central Nervous system metastases. J Neurooncol 2006; 13:1–6.
Scott Peak MD, Lauren E, Abrey MD. Chemotherapy and the Treatment Of Brain Metastases Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. Hematol Oncol Clin N Am 20 2006;1287–1295
Francois G. Kamar, and Jerome Posner, Brain metastases seminars in neurology/volume 30, number 3 ,2010,201-231
Barnholtz-Sloan JS, Sloan AE, Faith GD, Fawn D. Vigneau, Ping Lai, and Sawaya RE. Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System J. Clin Oncol 22:2865-2872.
Gaspar LE, Scott C, Murray K, Curran W .Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000; 47:1001-1006.
Sperduto CM, Watanabe Y, Mullan J. A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment. J Neurosurg 2008; 109(Suppl.):87-89.
Videtic GM, Reddy CA, Chao ST, Rice TW, Adelstein DJ, Barnett GH, Mekhail TM, Vogelbaum MA, Suh JH: Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification. Int J Radiat Oncol Biol Phys 2009; 75:1141-1147.
Sun Tao, Warrington, Nicole M, and Rubin, Joshua B.»Why does Jack, and not Jill, break his crown? Sex disparity in brain tumors.» Biology of Sex Differences, (3) 🙁 2012).
U.S. Cancer Statistics Working Group: United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-Based Report Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2010.
Cancer Incidence in Sweden (2007) National Board of Health and Welfare. Official Statistics of Sweden. Health and Diseases 2008. [en linia] Disponible en :http://www.socialstyrelsen.se/publikationer2008/2008-125-16.
Smedby KE, Brandt L, Backlund ML, Blomqvist P. Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer 2009; 101(11):1919-1924.
Faith G. Davis, Therese A. Dolecek, Bridget J. McCarthy and Jillano.Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data. Neuro Oncol 2012; 14(9):1171-1177.
Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 2009; 22(1):1-6.
Kalkanis SN, Kondziolka D, Gaspar LE. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96(1):33-43.
Ries LAG, Eisner MP, Kosary CL. SEER Cancer Statistics Review, 1973-1998. National Cancer Institute, Bethesda (MD). [en linia] Disponible en: http:// seer. cancer.gov /publications/
Sawaya R, Bindal RK, Lang FF. Metastatic brain tumors, in Kaye EL (ed): Brain Tumors 2nd Edition: An Encyclopedic Approach. London, UK, Churchill Livingstone, 2001, pp 999-1026.
Ismail-Khan R.; Bui MM. A Review of triple negative breast cancer. Cancer Control Journal of the Moffit Cancer Center. 2010; 17(3):173-176.
Lin NU and Winer EP. Brain metastases: the HER2 paradigm Clin Cancer Res 2007; 13(6):1648–55.
Lin NU. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases Cancer 113(10):2638–45
Munzone E, Casali C, Gaetano A, Botteri E. Outcome and clinico-biological characteristics of advanced breast cancer patients with surgically resected brain metastases: a multidisciplinary approached cancer 2013; 7:309.
Lassman AB, DeAngelis LM. Brain metastases. Neurol Clin 2003; 1:1–23.
Brem SS, Bierman PJ, Brem H. NCCN Clinical Practice Guidelines in Oncology for Central Nervous System Cancers. JNCCN–Journal of the National Comprehensive Cancer Network. 2011; 9(4):352-400.
Soffietti R, Cornu P, Delattre JY. Brain metastases. En: Gilhus NE, Barnes MP, Brainin M (Ed), European Handbook of Neurological Management 2011; 1:437-445.
Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist 2007; 12:884–898.
Bailon O, Chouahnia K, Augier A, Bouillet T, Se´ gole` ne Billot, Ire` ne Coman, Re´ nataUrsu, et al. Association of carboplatin pluspemetrexed in patients with brain metastases of lung adenocarcinoma.Neuro-Oncology 2012;14(4):491–495.
Marie-Adele SK, Oermann,Matthew E, Ewend G, Hoffman RB. Huma Chaudhry,and Brian Collins Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with distant intracranial failure Radiat Oncol. 2013; 8:64.
Gril B, Evans L, Palmieri D and Steeg PS. Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies Eur J Cancer 2010; 46(7):1204–10.
Tsukada Y, Fouad A, Pickren JW and Lane WW (2003) Central nervous system metastasis from breast carcinoma. Autopsy study Cancer 52(12) 2349-2354.
Dawood S, Lei X, Litton JK, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM. Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer. Cancer. 2012; 118(19):4652-9.
Tremont-Lukats IW, Bobustuc G, Lagos GK, Lolas K, Kyritsis AP, Puduvalli VK. (Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience. Cancer. 2003; 98:363–368.
Martel CL, Gumerlock PH, Meyers FJ, Lara PN. Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev 2003; 29:171–187.
Caffo O, Gernone A, Ortega C, Sava T, Carteni G, Facchini G, Re GL, Amadio P, Bortolus R, Pagliarulo V, Prati V, Veccia A, Galligioni E Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era. J Neurooncol 2012; 107:191–196.
Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W, et al. Brain Metastases from Prostate Cancer: An 11-Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis. J Neuroimaging. 2012:1552-6569.
Rovirosa A, Bodi R, Vicente P, Alastuey I, Giralt J, Salvador LCerebral metastases in adenocarcinoma of the colon. Rev Esp Enferm Dig. 2011; 79(4):281-3.
Nieder C, Pawinski A, Balteskard L. Colorectal cancer